From Bench to Business

Phyllis Whiteley, Ph.D.is currently Senior Vice President of Business Development and Licensing at Perlegen Sciences, in Mountain View, California.

Prior to joining Perlegen, Dr. Whiteley served as Vice President Strategic Portfolio Management, Global Pharma Research Strategy for F. Hoffman La Roche. During her ten year tenure with Roche she held various positions including Vice President Business Development and Global Licensing Director based in Basel, Switzerland and other research leadership positions including Vice President Global Alliances Research, North America. Prior to Roche, Dr. Whiteley was with Merck. She holds a Ph.D., Pharmacology from Washington University, St. Louis, Missouri.

Dr. Whiteley has over fifteen years experience in pharmaceutical research, development and business development. She has comprehensive experience in the management and implementation of research and therapeutics related to pharmacology, immunology, and inflammation resulting in multiple new chemical entities in clinical development. Dr. Whiteley has partnering and in-licensing expertise including identifying, negotiating, and managing alliances that have resulted in externally-derived clinical products.